Showing results (21-30 of 574) with videos related to
Sort By:
Pageof 58
Managed Care Interface|November 7, 2000
Predicting risk reduction of coronary disease in patients who are glucose intolerant: a comparison of treatment with fenofibrate and other lipid-modifying agentsS M Haffner, T AshrafThe American Journal of Medicine|August 1, 1997
Insulin resistance implications for type II diabetes mellitus and coronary heart diseaseS M Haffner, H MiettinenDiabetes Care|December 1, 1991
Dyslipidemia in type II diabetes. Implications for therapeutic interventionM P Stern, S M HaffnerDiabetes/Metabolism Reviews|February 1, 1990
Type II diabetes and its complications in Mexican AmericansM P Stern, S M HaffnerThe American Journal of Medicine|January 16, 1995
Endogenous sex hormones: impact on lipids, lipoproteins, and insulinS M Haffner, R A ValdezArteriosclerosis (Dallas, Tex.)|March 1, 1986
Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular diseaseM P Stern, S M HaffnerMetabolism: Clinical and Experimental|June 1, 1993
The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal womenS M Haffner, R L BauerThe American Journal of Cardiology|June 5, 1999
Role of fibrates in the management of hypertriglyceridemiaD J Rader, S M HaffnerArteriosclerosis, Thrombosis, and Vascular Biology|August 26, 1998
Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotypeD L Rainwater, S M HaffnerInternational Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|November 1, 1992
Excess androgenicity only partially explains the relationship between obesity and bone density in premenopausal womenS M Haffner, R L BauerPageof 58